Matt Page Matt Page, United Biosource, MEDTAP Institute, Bethesda Vaccinating all age groups against influenza is likely to be cost effective – that’s acccording to a study presented at IC
Matt Page
Matt Page, United Biosource, MEDTAP Institute, Bethesda
Vaccinating all age groups against influenza is likely to be cost effective – that’s acccording to a study presented at ICAAC by Matt Page. He told Derek Thorne that his investigation could warrant a reconsideration of policy in the United States, and that this was a question worth investigating in other countries too.
[audio:https://www.audiomedica.com/podcasting/icaac2005/matt_page.mp3]